Intermittent claudication. A risk profile from The Framingham Heart Study
- PMID: 9236415
- DOI: 10.1161/01.cir.96.1.44
Intermittent claudication. A risk profile from The Framingham Heart Study
Abstract
Background: Intermittent claudication identifies persons at increased risk for death and disability.
Methods and results: Using 38-year follow-up data for the original cohort in the Framingham Heart Study, we developed an intermittent claudication risk profile. Intermittent claudication occurred in a total of 381 men and women. Age, sex, serum cholesterol, hypertension, cigarette smoking, diabetes, and coronary heart disease were associated with an increased risk for claudication and were included in the profile. A pooled logistic regression model was used to compute the probability of intermittent claudication for specified levels of risk factors.
Conclusions: The intermittent claudication risk profile allows physicians to identify high-risk individuals during a routine office visit and can be used to educate patients about modifiable risk factors, particularly smoking and blood pressure. Improved compliance with risk factor modification strategies may result in a beneficial impact on survival.
Similar articles
-
Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study.Diabetes. 1989 Apr;38(4):504-9. doi: 10.2337/diab.38.4.504. Diabetes. 1989. PMID: 2925008
-
Intermittent claudication in Quebec men from 1974-1986: the Quebec Cardiovascular Study.Clin Invest Med. 1991 Apr;14(2):93-100. Clin Invest Med. 1991. PMID: 2060193
-
Prevalence of intermittent claudication and its effect on mortality.Acta Med Scand. 1982;211(4):249-56. doi: 10.1111/j.0954-6820.1982.tb01939.x. Acta Med Scand. 1982. PMID: 7102362
-
[Intermittent claudication--a major cardiovascular risk factor. Proposed guidelines for investigation and treatment].Lakartidningen. 1999 Mar 31;96(13):1585-90. Lakartidningen. 1999. PMID: 10218341 Review. Swedish.
-
[Clinical and biochemical parameters of patients with vascular stenosis in the lower extremities in the stage of intermittent claudication].Orv Hetil. 1995 Apr 16;136(16):817-22. Orv Hetil. 1995. PMID: 7644187 Review. Hungarian.
Cited by
-
Neutrophil‑to‑lymphocyte, platelet‑to‑lymphocyte and lymphocyte‑to‑monocyte ratios are associated with amputation rates in patients with peripheral arterial disease and diabetes mellitus who underwent revascularization: A Romanian regional center study.Exp Ther Med. 2022 Oct 3;24(5):703. doi: 10.3892/etm.2022.11639. eCollection 2022 Nov. Exp Ther Med. 2022. PMID: 36337294 Free PMC article.
-
Epidemiology of Peripheral Artery Disease and Polyvascular Disease.Circ Res. 2021 Jun 11;128(12):1818-1832. doi: 10.1161/CIRCRESAHA.121.318535. Epub 2021 Jun 10. Circ Res. 2021. PMID: 34110907 Free PMC article.
-
Diabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalities.World J Diabetes. 2016 Apr 10;7(7):153-64. doi: 10.4239/wjd.v7.i7.153. World J Diabetes. 2016. PMID: 27076876 Free PMC article. Review.
-
Visualizing Risk Prediction Models.PLoS One. 2015 Jul 15;10(7):e0132614. doi: 10.1371/journal.pone.0132614. eCollection 2015. PLoS One. 2015. PMID: 26176945 Free PMC article.
-
Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study.BMC Cardiovasc Disord. 2010 Aug 5;10:35. doi: 10.1186/1471-2261-10-35. BMC Cardiovasc Disord. 2010. PMID: 20687927 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical